Hospira, Inc. (NYSE:HSP)

CAPS Rating: 2 out of 5

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care.

Recs

0
Player Avatar DrStan (55.58) Submitted: 3/13/2007 4:10:08 PM : Underperform Start Price: $39.28 HSP Score: +18.85

I owned this stock when it split from Abbott and sold it at a profit. There are too many good competitors lined up against it.

Featured Broker Partners


Advertisement